Oasis Extracellular Matrix - Biochemically-interactive dressing

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Disponível em:

William A Cook Australia Pty Ltd

Classe:

Class III

Fabricado por:

Cook Biotech Incorporated 1425 Innovation Place, West Lafayette, Indiana, 47906 United States Of America

Área terapêutica:

34083 - Biochemically-interactive dressing

Indicações terapêuticas:

OASIS Extracellular Matrix is derived using a process that retains the natural composition of matrix molecules. It functions by binding to the receptors on the cells to activate cellular processes, such as replication and growth factor secretion. Oasis Extracellular Matrix is indicated for the management of wounds including: ? Partial and full-thickness wounds ? Pressure Ulcers ? Venous ulcers ? Chronic vascular ulcers ? Diabetic ulcers ? Second-degree burns ? Third-degree burns ? Trauma wounds (abrasions, lacerations, skin tears) ? Donor sites/grafts ? Draining wounds ? Surgical wounds (post-Mohs? surgery, post-laser surgery, podiatric, wound dehiscence)

Status de autorização:

A

Data de autorização:

2018-03-08